View Article

Abstract

Drug resistance is the ability of microorganisms, such as bacteria, viruses, or parasites, to withstand the effects of drugs that were intended to kill or inhibit their growth. In developed countries, drug resistance is the primary cause of death, the burden of infectious diseases is comparatively greater, and patients with a resistance are less likely to be able to afford secondary line treatments, which typically have more complex regimens than first line drugs. Nowadays, antibiotic resistance is increasing. Some of the common drug resistances like Bacteria, Cancer, Diabetes, Leprosy, and HIV. These are the main cause of efflux protein resistance, which happens when diseases become tolerant to the pharmaceutical treatments.

Keywords

Drug resistance, Anti diabetes, Efflux proteins, Malignant neoplasm.

Reference

  1. Sender R, Fuchs S, Milo R (19 August 2016). "Revised Estimates for the Number of Human and Bacteria Cells in the Body". PLOS Biology. 14 (8): e1002533. doi:10.1371/journal.pbio.1002533. ISSN 1545-7885. PMC 4991899. PMID 27541692.
  2. Levy, S. The Antibiotic Paradox: How Misuse of Antibiotics Destroys their Curative Powers (Perseus Cambridge, 2002).
  3. Wang, H., Dzink-Fox, J.L., Chen, M. & Levy, S.B. Genetic characterization of highly fluoroquinolone-resistant clinical Escherichia coli strains from China: role of acrR mutations. Antimicrobe.
  4. Levy SB. Chadwick DJ, Goode J. Vol. 1. 2007: Chichester, UK; 2007. Antibiotic Resistance: An Ecological Imbalance, in Ciba Foundation Symposium 207 - Antibiotic Resistance: Origins, Evolution, Selection and Spread.
  5. Levy SB. The Antibiotic Paradox. Springer: 1992. From tragedy the antibiotic age is born; pp. 1–12.
  6. Levy SB. N Engl J Med. Vol. 328. Plenum Press: York; 1993. The antimicrobial paradox. How miracle drugs are destroying the miracle; p. 1792.
  7. Emergence and dissemination of quinolone-resistant Escherichia coli in the community. Garau J, Xercavins M, Rodríguez-Carballeira M, et al. http://aac.asm.org/content/43/11/2736.short. Antimicrobe Agents Chemother. 1999;43:2736–2741.
  8. Roy, P.; Saikia, B. Cancer and cure: A critical analysis. Indian J. Cancer 2016, 53, 441–442.
  9. Blackadar CB: Historical review of the cause of cancer. World J Clin Oncol 2016; 7(1).
  10. Http://www.cancer.gov/about-cancer/typesofcancer.
  11. Https://www.britannica.com/science/antidiabetic-drug.
  12. https://images.app.goo.gl/LBbTzSKXwp7xvuWC6.
  13. Han XY, Seo YSH, Sizer KC, Schoberle T, May GS, Spencer JS, et al. A new Mycobacterium species causing diffuse lepromatous leprosy. Am J Clin Path.
  14. Zhu YI, Stiller MJ. Dapsone and sulfones in dermatology: Overview and update. J Am Acad Dermatol. 2001;45:42034.
  15. Scollard DM, Adams LB, Gillis TP, Krahenbuhl JL, Truman RW, Williams DL. The continuing challenges of leprosy. Clin Microbiol Rev. 2006 Apr;19(2):338.
  16. Valverde CR, Canfield D, Tarara R, Esteves MI, Gormus BJ. Spontaneous leprosy in a wild-caught cynomolgus macaque. Int J Lepr Other Mycobact Dis. 1998 Jun;66(2):140-8.
  17. Valverde CR, Canfield D, Tarara R, Esteves MI, Gormus BJ. Spontaneous leprosy in a wild-caught cynomolgus macaque. Int J Lepr Other Mycobact Dis. 1998 Jun;66(2):140-8
  18. Rom WN, Markowitz SB, eds. (2007). Environmental and occupational medicine (4th ed.). Philadelphia: Wolters Kluwer/Lippincott Williams & Wilkins. p. 745. ISBN 978-0-7817- 6299-1. Archived from the original on September 11, 2015. Retrieved June 27, 2015.
  19. Eiglmeier K, Parkhill J, Honoré N, Garnier T, Tekaia F, Telenti A, Klatser P, James KD, Thomson NR, Wheeler PR, Churcher C, Harris D, Mungall K, Barrell BG, Cole ST. The decaying genome of Mycobacterium leprae. Lepr Rev. 2001 Dec;72(4):387-98

Photo
T. V. Sowjanya
Corresponding author

NRI College of pharmacy

Photo
B. Akhila
Co-author

NRI College of pharmacy

Photo
N. Ahalya
Co-author

NRI College of pharmacy

Photo
T. Sai Ram
Co-author

NRI College of pharmacy

Photo
T. Maneesha
Co-author

NRI College of pharmacy

Photo
V. Pavithra
Co-author

NRI College of pharmacy

T.V. Sowjanya, B. Akhila , N. Ahalya, T. Sai Ram, T. Maneesha, V. Pavithra, Drug Resistance In Various Disorders, Int. J. of Pharm. Sci., 2024, Vol 2, Issue 2, 558-564. https://doi.org/10.5281/zenodo.10684813

More related articles
Pioglitazone Matrix Patches: In Vitro Methodologie...
Ningaraj Arer, Hanamant B Sannakki, Vishwanath Halappanavar, Shri...
Unlocking The Potential Of Chrysin: A Comprehensiv...
Chetna K. Dhone, Shagufta A. Khan, ...
Nanoemulgel As A Novel Carrier for Topical Drug Delivery System: A Brief Review...
Manjunath T., Ganesh N. S., Adlin Jino Nesalin, Vineeth Chandy, ...
Comparative Analysis of Mucoadhesive Patches and Oral Disintegrating Films for B...
Mehak Gupta, Dr. Daisy Sharma , Gopal Thakur, Arshiya Sharma, Aparna Thakur, ...
Related Articles
A Brief Review on Spirulina Plantensis Syrup for Gut Microbiota Health ...
Agalvae Vaishnavi , Ghadge Dnyaneshwari , Phacpute Sayali , Kamble Rachana , ...
Pioglitazone Matrix Patches: In Vitro Methodologies And Efficacy Assessment - A ...
Ningaraj Arer, Hanamant B Sannakki, Vishwanath Halappanavar, Shridhar Gaikwad, Adarsh Utale, ...
More related articles
Pioglitazone Matrix Patches: In Vitro Methodologies And Efficacy Assessment - A ...
Ningaraj Arer, Hanamant B Sannakki, Vishwanath Halappanavar, Shridhar Gaikwad, Adarsh Utale, ...